Business Description
PharmaCorp Rx Inc
NAICS : 414510
SIC : 6031
ISIN : CA74373X1015
Total Employee Number:
5Compare
Compare
Traded in other countries / regions
PCRX.Canada IPO Date
2022-05-16Description
PharmaCorp Rx Inc operates three PharmaChoice bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada-branded pharmacies as it come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The company will also acquire independently owned non-PharmaChoice Canada-bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 5.43 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | 6.7 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.52 | |||||
Beneish M-Score | -1.75 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | 20.6 | |||||
3-Year FCF Growth Rate | 37 | |||||
3-Year Book Growth Rate | 63.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 62.76 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 14.83 | |||||
9-Day RSI | 23.05 | |||||
14-Day RSI | 30.28 | |||||
3-1 Month Momentum % | -1 | |||||
6-1 Month Momentum % | 8.79 | |||||
12-1 Month Momentum % | 3.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.36 | |||||
Quick Ratio | 6.56 | |||||
Cash Ratio | 6.12 | |||||
Days Inventory | 57.45 | |||||
Days Sales Outstanding | 13.94 | |||||
Days Payable | 69.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -63.3 | |||||
Shareholder Yield % | -4 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 39.53 | |||||
Operating Margin % | -4.77 | |||||
Net Margin % | -4.17 | |||||
EBITDA Margin % | 2.41 | |||||
FCF Margin % | 0.16 | |||||
OCF Margin % | 0.84 | |||||
ROE % | -2.63 | |||||
ROA % | -2.13 | |||||
ROIC % | -3.93 | |||||
ROC (Joel Greenblatt) % | -10.25 | |||||
ROCE % | -1.18 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 19.57 | |||||
PS Ratio | 2.46 | |||||
PB Ratio | 1.41 | |||||
Price-to-Tangible-Book | 3.29 | |||||
Price-to-Free-Cash-Flow | 61.07 | |||||
Price-to-Operating-Cash-Flow | 85.5 | |||||
EV-to-EBIT | -116.23 | |||||
EV-to-EBITDA | 103.57 | |||||
EV-to-Forward-EBITDA | 6.4 | |||||
EV-to-Revenue | 2.5 | |||||
EV-to-Forward-Revenue | 0.82 | |||||
EV-to-FCF | 1592.14 | |||||
| Price-to-Net-Current-Asset-Value | 4.28 | |||||
| Price-to-Net-Cash | 6.11 | |||||
Earnings Yield (Greenblatt) % | -0.86 | |||||
FCF Yield % | 0.05 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PharmaCorp Rx Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 27.408 | ||
| EPS (TTM) (C$) | -0.01 | ||
| Beta | 1.722 | ||
| 3-Year Sharpe Ratio | 0.5 | ||
| 3-Year Sortino Ratio | 2.99 | ||
| Volatility % | 26.07 | ||
| 14-Day RSI | 30.28 | ||
| 14-Day ATR (C$) | 0.011654 | ||
| 20-Day SMA (C$) | 0.480875 | ||
| 12-1 Month Momentum % | 3.13 | ||
| 52-Week Range (C$) | 0.4 - 0.58 | ||
| Shares Outstanding (Mil) | 196.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PharmaCorp Rx Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PharmaCorp Rx Inc Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
PharmaCorp Rx Inc Frequently Asked Questions
What is PharmaCorp Rx Inc(TSXV:PCRX)'s stock price today?
The current price of TSXV:PCRX is C$0.43. The 52 week high of TSXV:PCRX is C$0.58 and 52 week low is C$0.40.
When is next earnings date of PharmaCorp Rx Inc(TSXV:PCRX)?
The next earnings date of PharmaCorp Rx Inc(TSXV:PCRX) is .
Does PharmaCorp Rx Inc(TSXV:PCRX) pay dividends? If so, how much?
PharmaCorp Rx Inc(TSXV:PCRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers